Amsalih, Amaarah .
HRN: 21-83-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
MUPIROCIN 2%, 15G (TUBE)
03/27/2023
04/02/2023
TOPICAL
Pea Size
BID
Phlebitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes